

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.93310622 |
| 2 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.32481412 |
| 3 | myelination (GO:0042552) | 5.15121372 |
| 4 | ensheathment of neurons (GO:0007272) | 5.14817840 |
| 5 | axon ensheathment (GO:0008366) | 5.14817840 |
| 6 | cholesterol biosynthetic process (GO:0006695) | 5.04959790 |
| 7 | protein neddylation (GO:0045116) | 4.83308326 |
| 8 | regulation of somitogenesis (GO:0014807) | 4.81485074 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.50967539 |
| 10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.47416838 |
| 11 | sterol biosynthetic process (GO:0016126) | 4.44695488 |
| 12 | isoprenoid biosynthetic process (GO:0008299) | 4.35895804 |
| 13 | regulation of collateral sprouting (GO:0048670) | 4.23127436 |
| 14 | chaperone-mediated protein transport (GO:0072321) | 4.18218564 |
| 15 | limb bud formation (GO:0060174) | 4.17507017 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.11083326 |
| 17 | response to redox state (GO:0051775) | 4.10769007 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.96796568 |
| 19 | ATP synthesis coupled proton transport (GO:0015986) | 3.96796568 |
| 20 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.88888740 |
| 21 | NADH dehydrogenase complex assembly (GO:0010257) | 3.88888740 |
| 22 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.88888740 |
| 23 | GPI anchor biosynthetic process (GO:0006506) | 3.82626353 |
| 24 | response to methylmercury (GO:0051597) | 3.80367625 |
| 25 | myelin maintenance (GO:0043217) | 3.77784697 |
| 26 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.74119747 |
| 27 | L-amino acid import (GO:0043092) | 3.66263453 |
| 28 | negative regulation of protein localization to cell surface (GO:2000009) | 3.65774677 |
| 29 | substantia nigra development (GO:0021762) | 3.61770991 |
| 30 | negative regulation of neurotransmitter transport (GO:0051589) | 3.59502006 |
| 31 | eye photoreceptor cell differentiation (GO:0001754) | 3.59479346 |
| 32 | photoreceptor cell differentiation (GO:0046530) | 3.59479346 |
| 33 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.57849765 |
| 34 | positive regulation of protein autophosphorylation (GO:0031954) | 3.56066224 |
| 35 | sphingoid metabolic process (GO:0046519) | 3.54897975 |
| 36 | nucleotide transmembrane transport (GO:1901679) | 3.53591224 |
| 37 | amyloid precursor protein metabolic process (GO:0042982) | 3.49169243 |
| 38 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.47613634 |
| 39 | GPI anchor metabolic process (GO:0006505) | 3.45042644 |
| 40 | oligodendrocyte differentiation (GO:0048709) | 3.43052766 |
| 41 | glycerophospholipid catabolic process (GO:0046475) | 3.41458062 |
| 42 | neuron remodeling (GO:0016322) | 3.37831307 |
| 43 | ribosome assembly (GO:0042255) | 3.36046556 |
| 44 | establishment of mitochondrion localization (GO:0051654) | 3.35852835 |
| 45 | respiratory electron transport chain (GO:0022904) | 3.35210778 |
| 46 | cullin deneddylation (GO:0010388) | 3.33856841 |
| 47 | ribonucleoprotein complex disassembly (GO:0032988) | 3.33331140 |
| 48 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.31825518 |
| 49 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.29470401 |
| 50 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.27847507 |
| 51 | organelle disassembly (GO:1903008) | 3.27203740 |
| 52 | electron transport chain (GO:0022900) | 3.25244693 |
| 53 | magnesium ion transport (GO:0015693) | 3.24374598 |
| 54 | mannosylation (GO:0097502) | 3.23591171 |
| 55 | protein deneddylation (GO:0000338) | 3.21146910 |
| 56 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.17920938 |
| 57 | import into cell (GO:0098657) | 3.16051288 |
| 58 | positive regulation of actin filament depolymerization (GO:0030836) | 3.06927411 |
| 59 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 3.06688582 |
| 60 | protein complex biogenesis (GO:0070271) | 3.05416473 |
| 61 | protein targeting to mitochondrion (GO:0006626) | 2.99160951 |
| 62 | sphingosine metabolic process (GO:0006670) | 2.98530692 |
| 63 | lipid particle organization (GO:0034389) | 2.98448758 |
| 64 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.97303727 |
| 65 | respiratory chain complex IV assembly (GO:0008535) | 2.95869690 |
| 66 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.94540299 |
| 67 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.94418072 |
| 68 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.93236209 |
| 69 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.92191641 |
| 70 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.92191641 |
| 71 | dopamine biosynthetic process (GO:0042416) | 2.91865664 |
| 72 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.88908121 |
| 73 | platelet dense granule organization (GO:0060155) | 2.88458313 |
| 74 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.87878376 |
| 75 | protein localization to mitochondrion (GO:0070585) | 2.87531099 |
| 76 | cranial nerve development (GO:0021545) | 2.87025308 |
| 77 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.86186710 |
| 78 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.85933377 |
| 79 | maturation of 5.8S rRNA (GO:0000460) | 2.84763249 |
| 80 | neurotransmitter uptake (GO:0001504) | 2.80849317 |
| 81 | establishment of protein localization to mitochondrion (GO:0072655) | 2.80596862 |
| 82 | rRNA modification (GO:0000154) | 2.80167951 |
| 83 | tissue regeneration (GO:0042246) | 2.79973909 |
| 84 | ribosomal small subunit biogenesis (GO:0042274) | 2.79247041 |
| 85 | axon development (GO:0061564) | 2.78972792 |
| 86 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.77719666 |
| 87 | astrocyte development (GO:0014002) | 2.77448487 |
| 88 | microtubule polymerization or depolymerization (GO:0031109) | 2.77427767 |
| 89 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.76885398 |
| 90 | otic vesicle formation (GO:0030916) | 2.76737807 |
| 91 | negative regulation of ligase activity (GO:0051352) | 2.75183207 |
| 92 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.75183207 |
| 93 | negative regulation of acute inflammatory response (GO:0002674) | 2.74751491 |
| 94 | lateral sprouting from an epithelium (GO:0060601) | 2.73063321 |
| 95 | pseudouridine synthesis (GO:0001522) | 2.70846911 |
| 96 | very long-chain fatty acid metabolic process (GO:0000038) | 2.70189535 |
| 97 | creatine metabolic process (GO:0006600) | 2.69519999 |
| 98 | protein heterotetramerization (GO:0051290) | 2.68736396 |
| 99 | proteasome assembly (GO:0043248) | 2.68318603 |
| 100 | diol metabolic process (GO:0034311) | 2.67847516 |
| 101 | amino acid import (GO:0043090) | 2.66775853 |
| 102 | keratinocyte development (GO:0003334) | 2.66197186 |
| 103 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.64696140 |
| 104 | cell adhesion mediated by integrin (GO:0033627) | 2.62762898 |
| 105 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.62643476 |
| 106 | response to lipoprotein particle (GO:0055094) | 2.62637226 |
| 107 | presynaptic membrane organization (GO:0097090) | 2.61796790 |
| 108 | positive regulation of pseudopodium assembly (GO:0031274) | 2.60040210 |
| 109 | negative regulation of chemokine production (GO:0032682) | 2.58707323 |
| 110 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.58076935 |
| 111 | histone H2B ubiquitination (GO:0033523) | 2.58012766 |
| 112 | ear development (GO:0043583) | 2.57845769 |
| 113 | termination of RNA polymerase III transcription (GO:0006386) | 2.55542021 |
| 114 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.55542021 |
| 115 | enteric nervous system development (GO:0048484) | 2.55458022 |
| 116 | signal peptide processing (GO:0006465) | 2.55031227 |
| 117 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.54193607 |
| 118 | rRNA methylation (GO:0031167) | 2.53989973 |
| 119 | positive regulation of ligase activity (GO:0051351) | 2.53835240 |
| 120 | intracellular protein transmembrane import (GO:0044743) | 2.53374269 |
| 121 | apical protein localization (GO:0045176) | 2.52880814 |
| 122 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.52680517 |
| 123 | cellular copper ion homeostasis (GO:0006878) | 2.52085913 |
| 124 | nucleotide transport (GO:0006862) | 2.51059033 |
| 125 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.50011291 |
| 126 | protein palmitoylation (GO:0018345) | 2.49835165 |
| 127 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.49770762 |
| 128 | neural nucleus development (GO:0048857) | 2.48417606 |
| 129 | membrane lipid biosynthetic process (GO:0046467) | 2.48158023 |
| 130 | peptidyl-cysteine modification (GO:0018198) | 2.47934699 |
| 131 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.45993597 |
| 132 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.45030516 |
| 133 | protein K6-linked ubiquitination (GO:0085020) | 2.44811801 |
| 134 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.44631391 |
| 135 | amyloid precursor protein catabolic process (GO:0042987) | 2.44458850 |
| 136 | 7-methylguanosine mRNA capping (GO:0006370) | 2.43022998 |
| 137 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.42355848 |
| 138 | N-acetylglucosamine metabolic process (GO:0006044) | 2.41885507 |
| 139 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.41609007 |
| 140 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.41496508 |
| 141 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.41496508 |
| 142 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.41496508 |
| 143 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.39792656 |
| 144 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.39792656 |
| 145 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.39491122 |
| 146 | heart process (GO:0003015) | 2.38963708 |
| 147 | heart contraction (GO:0060047) | 2.38963708 |
| 148 | cytochrome complex assembly (GO:0017004) | 2.36246644 |
| 149 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.36205509 |
| 150 | regulation of ligase activity (GO:0051340) | 2.35100810 |
| 151 | protein-cofactor linkage (GO:0018065) | 2.35084505 |
| 152 | RNA capping (GO:0036260) | 2.34033988 |
| 153 | 7-methylguanosine RNA capping (GO:0009452) | 2.34033988 |
| 154 | regulation of protein autophosphorylation (GO:0031952) | 2.33210154 |
| 155 | regulation of DNA endoreduplication (GO:0032875) | 2.31086138 |
| 156 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.30993375 |
| 157 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.30939941 |
| 158 | amino acid salvage (GO:0043102) | 2.30283681 |
| 159 | L-methionine salvage (GO:0071267) | 2.30283681 |
| 160 | L-methionine biosynthetic process (GO:0071265) | 2.30283681 |
| 161 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.28914704 |
| 162 | wound healing, spreading of epidermal cells (GO:0035313) | 2.28892186 |
| 163 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.28601082 |
| 164 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.28601082 |
| 165 | regulation of glomerulus development (GO:0090192) | 2.26188017 |
| 166 | peptidyl-histidine modification (GO:0018202) | 2.24643016 |
| 167 | anterior/posterior axis specification, embryo (GO:0008595) | 2.24155516 |
| 168 | ER overload response (GO:0006983) | 2.21640542 |
| 169 | hydrogen ion transmembrane transport (GO:1902600) | 2.20766427 |
| 170 | mitochondrial transport (GO:0006839) | 2.20230089 |
| 171 | protein K11-linked ubiquitination (GO:0070979) | 2.19902588 |
| 172 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.19114655 |
| 173 | inner mitochondrial membrane organization (GO:0007007) | 2.15689232 |
| 174 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.15017106 |
| 175 | response to nitrosative stress (GO:0051409) | 2.14293902 |
| 176 | axon ensheathment in central nervous system (GO:0032291) | 10.0850732 |
| 177 | central nervous system myelination (GO:0022010) | 10.0850732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.86891363 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.14292151 |
| 3 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.31605654 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.81409544 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.67413186 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.61120261 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.47725743 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.44113641 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.42389636 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.42234303 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.35287682 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.33813135 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.32457656 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.26424504 |
| 15 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.23710468 |
| 16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.10298348 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.09338797 |
| 18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.06757159 |
| 19 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.01059172 |
| 20 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88366078 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.86275180 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.85155587 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.82024236 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80427860 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.78946164 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.78904519 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77372059 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74942758 |
| 29 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74131917 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.73139517 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.69028040 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.68084440 |
| 33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.67411849 |
| 34 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.67243956 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66963701 |
| 36 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.66259673 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65869364 |
| 38 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.65313969 |
| 39 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.62423446 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.61570863 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.59576159 |
| 42 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.58312448 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57259482 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55788076 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.52890826 |
| 46 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51687063 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.48277452 |
| 48 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.45671416 |
| 49 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.44709346 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42943677 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40053716 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39708066 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39577668 |
| 54 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.38656150 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38573208 |
| 56 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.37648102 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36682088 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36383906 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.34874063 |
| 60 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.34874063 |
| 61 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.34293612 |
| 62 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.34253293 |
| 63 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33493518 |
| 64 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32362470 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32222886 |
| 66 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32126718 |
| 67 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31842304 |
| 68 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31551862 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30923660 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30530110 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28662603 |
| 72 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28307759 |
| 73 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28272801 |
| 74 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27402163 |
| 75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.27353276 |
| 76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27113874 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25953521 |
| 78 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.25337560 |
| 79 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.24740465 |
| 80 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24712898 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24656129 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24619840 |
| 83 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.24263869 |
| 84 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.24156441 |
| 85 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23792041 |
| 86 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23307700 |
| 87 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22855582 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22357607 |
| 89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21999713 |
| 90 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21909382 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21566027 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21248322 |
| 93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20536673 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19102229 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19102229 |
| 96 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15614754 |
| 97 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.15553890 |
| 98 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15431324 |
| 99 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14881868 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14798524 |
| 101 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14787403 |
| 102 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14787403 |
| 103 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.13579065 |
| 104 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.13499471 |
| 105 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.13399427 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13363867 |
| 107 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13327815 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13130273 |
| 109 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12090426 |
| 110 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.11053083 |
| 111 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.10272204 |
| 112 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09474130 |
| 113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09342057 |
| 114 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.08138376 |
| 115 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07851581 |
| 116 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07496022 |
| 117 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06608249 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06536352 |
| 119 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.05814802 |
| 120 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05654782 |
| 121 | JUN_21703547_ChIP-Seq_K562_Human | 1.04894480 |
| 122 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.04524040 |
| 123 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.03975948 |
| 124 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02571998 |
| 125 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02341859 |
| 126 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.02145008 |
| 127 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.01899985 |
| 128 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.01573674 |
| 129 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01297555 |
| 130 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99951524 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99545773 |
| 132 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99485294 |
| 133 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99043894 |
| 134 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98169024 |
| 135 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.98152303 |
| 136 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.98005994 |
| 137 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.97984036 |
| 138 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97536439 |
| 139 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96757510 |
| 140 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96625402 |
| 141 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96479537 |
| 142 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96078446 |
| 143 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95922690 |
| 144 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93724511 |
| 145 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93610276 |
| 146 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93607403 |
| 147 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93527230 |
| 148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93031700 |
| 149 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.92689378 |
| 150 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92539205 |
| 151 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91922271 |
| 152 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.91711384 |
| 153 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91137742 |
| 154 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90697693 |
| 155 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90125452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.26274242 |
| 2 | MP0003136_yellow_coat_color | 3.50086667 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.48702279 |
| 4 | MP0001529_abnormal_vocalization | 2.98898394 |
| 5 | MP0003880_abnormal_central_pattern | 2.89221290 |
| 6 | MP0004381_abnormal_hair_follicle | 2.87499301 |
| 7 | MP0001346_abnormal_lacrimal_gland | 2.80211497 |
| 8 | MP0001905_abnormal_dopamine_level | 2.78397672 |
| 9 | MP0003941_abnormal_skin_development | 2.68622396 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.66964260 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.56415366 |
| 12 | MP0000383_abnormal_hair_follicle | 2.54044520 |
| 13 | MP0005451_abnormal_body_composition | 2.42899253 |
| 14 | MP0003195_calcinosis | 2.39524978 |
| 15 | MP0008260_abnormal_autophagy | 2.36216221 |
| 16 | MP0004270_analgesia | 2.35135734 |
| 17 | MP0004742_abnormal_vestibular_system | 2.28331886 |
| 18 | MP0009379_abnormal_foot_pigmentation | 2.28117347 |
| 19 | MP0005171_absent_coat_pigmentation | 2.20332771 |
| 20 | MP0006054_spinal_hemorrhage | 2.18668093 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.15690169 |
| 22 | MP0010678_abnormal_skin_adnexa | 2.09183891 |
| 23 | MP0001485_abnormal_pinna_reflex | 2.00585804 |
| 24 | MP0000566_synostosis | 1.94018271 |
| 25 | MP0000647_abnormal_sebaceous_gland | 1.93907168 |
| 26 | MP0000749_muscle_degeneration | 1.92363514 |
| 27 | MP0004142_abnormal_muscle_tone | 1.91550905 |
| 28 | MP0003718_maternal_effect | 1.88444682 |
| 29 | MP0004885_abnormal_endolymph | 1.81038306 |
| 30 | MP0000372_irregular_coat_pigmentation | 1.80891676 |
| 31 | MP0005409_darkened_coat_color | 1.80023405 |
| 32 | MP0000762_abnormal_tongue_morphology | 1.76494432 |
| 33 | MP0001486_abnormal_startle_reflex | 1.75550896 |
| 34 | MP0002009_preneoplasia | 1.75278933 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.69525118 |
| 36 | MP0009053_abnormal_anal_canal | 1.68929719 |
| 37 | MP0002272_abnormal_nervous_system | 1.68185123 |
| 38 | MP0003690_abnormal_glial_cell | 1.65660182 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.65477794 |
| 40 | MP0003646_muscle_fatigue | 1.64755475 |
| 41 | MP0000778_abnormal_nervous_system | 1.63174700 |
| 42 | MP0000516_abnormal_urinary_system | 1.61787472 |
| 43 | MP0005367_renal/urinary_system_phenotyp | 1.61787472 |
| 44 | MP0004272_abnormal_basement_membrane | 1.60592853 |
| 45 | MP0003634_abnormal_glial_cell | 1.59861767 |
| 46 | MP0002796_impaired_skin_barrier | 1.58527934 |
| 47 | MP0002734_abnormal_mechanical_nocicepti | 1.57363942 |
| 48 | MP0009046_muscle_twitch | 1.56739983 |
| 49 | MP0004147_increased_porphyrin_level | 1.56095220 |
| 50 | MP0005410_abnormal_fertilization | 1.52609354 |
| 51 | MP0003329_amyloid_beta_deposits | 1.51104251 |
| 52 | MP0008058_abnormal_DNA_repair | 1.49726809 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.47857202 |
| 54 | MP0005408_hypopigmentation | 1.45757208 |
| 55 | MP0002102_abnormal_ear_morphology | 1.44418349 |
| 56 | MP0004957_abnormal_blastocyst_morpholog | 1.41265889 |
| 57 | MP0002090_abnormal_vision | 1.39096338 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.38962458 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 1.38904473 |
| 60 | MP0005423_abnormal_somatic_nervous | 1.36481681 |
| 61 | MP0002163_abnormal_gland_morphology | 1.33910545 |
| 62 | MP0002064_seizures | 1.31021738 |
| 63 | MP0003938_abnormal_ear_development | 1.29926143 |
| 64 | MP0005187_abnormal_penis_morphology | 1.28002230 |
| 65 | MP0000579_abnormal_nail_morphology | 1.26342168 |
| 66 | MP0000358_abnormal_cell_content/ | 1.26270633 |
| 67 | MP0004134_abnormal_chest_morphology | 1.24857093 |
| 68 | MP0004215_abnormal_myocardial_fiber | 1.24654132 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.24333746 |
| 70 | MP0001963_abnormal_hearing_physiology | 1.23876829 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 1.23868422 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 1.23282097 |
| 73 | MP0001851_eye_inflammation | 1.23125364 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.22485819 |
| 75 | MP0001440_abnormal_grooming_behavior | 1.19918989 |
| 76 | MP0008789_abnormal_olfactory_epithelium | 1.18834911 |
| 77 | MP0002229_neurodegeneration | 1.18227476 |
| 78 | MP0006276_abnormal_autonomic_nervous | 1.17580931 |
| 79 | MP0005623_abnormal_meninges_morphology | 1.17412703 |
| 80 | MP0009250_abnormal_appendicular_skeleto | 1.16722610 |
| 81 | MP0001970_abnormal_pain_threshold | 1.16408587 |
| 82 | MP0005275_abnormal_skin_tensile | 1.15915322 |
| 83 | MP0003632_abnormal_nervous_system | 1.14335198 |
| 84 | MP0000569_abnormal_digit_pigmentation | 1.13194733 |
| 85 | MP0000026_abnormal_inner_ear | 1.11615059 |
| 86 | MP0002752_abnormal_somatic_nervous | 1.11520434 |
| 87 | MP0003937_abnormal_limbs/digits/tail_de | 1.10977975 |
| 88 | MP0008932_abnormal_embryonic_tissue | 1.09715367 |
| 89 | MP0002254_reproductive_system_inflammat | 1.09675173 |
| 90 | MP0002735_abnormal_chemical_nociception | 1.09601451 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 1.08358209 |
| 92 | MP0000343_altered_response_to | 1.05443039 |
| 93 | MP0002282_abnormal_trachea_morphology | 1.03861893 |
| 94 | MP0001542_abnormal_bone_strength | 1.03533985 |
| 95 | MP0002876_abnormal_thyroid_physiology | 1.03377782 |
| 96 | MP0002060_abnormal_skin_morphology | 1.00350630 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.99487673 |
| 98 | MP0001661_extended_life_span | 0.99081712 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.97840812 |
| 100 | MP0000462_abnormal_digestive_system | 0.96296214 |
| 101 | MP0004233_abnormal_muscle_weight | 0.95842815 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.94859074 |
| 103 | MP0003279_aneurysm | 0.94599958 |
| 104 | MP0001340_abnormal_eyelid_morphology | 0.94505474 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.93854298 |
| 106 | MP0002882_abnormal_neuron_morphology | 0.93774052 |
| 107 | MP0002160_abnormal_reproductive_system | 0.92509515 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.92224805 |
| 109 | MP0002972_abnormal_cardiac_muscle | 0.91421267 |
| 110 | MP0005195_abnormal_posterior_eye | 0.90758796 |
| 111 | MP0002938_white_spotting | 0.90224042 |
| 112 | MP0010771_integument_phenotype | 0.90102102 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.90062051 |
| 114 | MP0000613_abnormal_salivary_gland | 0.89950579 |
| 115 | MP0005620_abnormal_muscle_contractility | 0.87984778 |
| 116 | MP0005332_abnormal_amino_acid | 0.87926443 |
| 117 | MP0002751_abnormal_autonomic_nervous | 0.87746991 |
| 118 | MP0005501_abnormal_skin_physiology | 0.87498256 |
| 119 | MP0002277_abnormal_respiratory_mucosa | 0.87229186 |
| 120 | MP0000013_abnormal_adipose_tissue | 0.86769415 |
| 121 | MP0000377_abnormal_hair_follicle | 0.85159935 |
| 122 | MP0000750_abnormal_muscle_regeneration | 0.84958919 |
| 123 | MP0000427_abnormal_hair_cycle | 0.84638257 |
| 124 | MP0002177_abnormal_outer_ear | 0.84479761 |
| 125 | MP0010030_abnormal_orbit_morphology | 0.83648820 |
| 126 | MP0008569_lethality_at_weaning | 0.83470582 |
| 127 | MP0002733_abnormal_thermal_nociception | 0.82394389 |
| 128 | MP0010368_abnormal_lymphatic_system | 0.82158763 |
| 129 | MP0003631_nervous_system_phenotype | 0.81770262 |
| 130 | MP0004043_abnormal_pH_regulation | 0.81626257 |
| 131 | MP0000955_abnormal_spinal_cord | 0.81498453 |
| 132 | MP0001243_abnormal_dermal_layer | 0.81207801 |
| 133 | MP0002067_abnormal_sensory_capabilities | 0.80885187 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.80470458 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.79813538 |
| 136 | MP0003755_abnormal_palate_morphology | 0.79808813 |
| 137 | MP0009745_abnormal_behavioral_response | 0.78430469 |
| 138 | MP0001968_abnormal_touch/_nociception | 0.78209501 |
| 139 | MP0008007_abnormal_cellular_replicative | 0.78091476 |
| 140 | MP0003123_paternal_imprinting | 0.77997927 |
| 141 | MP0001177_atelectasis | 0.76798924 |
| 142 | MP0002233_abnormal_nose_morphology | 0.76298399 |
| 143 | MP0002572_abnormal_emotion/affect_behav | 0.75803798 |
| 144 | MP0003786_premature_aging | 0.75695664 |
| 145 | MP0006082_CNS_inflammation | 0.75178975 |
| 146 | MP0002736_abnormal_nociception_after | 0.74672286 |
| 147 | MP0005197_abnormal_uvea_morphology | 0.74154656 |
| 148 | MP0001764_abnormal_homeostasis | 0.74063609 |
| 149 | MP0000467_abnormal_esophagus_morphology | 0.74011821 |
| 150 | MP0005253_abnormal_eye_physiology | 0.73760576 |
| 151 | MP0003186_abnormal_redox_activity | 0.73156826 |
| 152 | MP0003656_abnormal_erythrocyte_physiolo | 0.72986379 |
| 153 | MP0002066_abnormal_motor_capabilities/c | 0.72823476 |
| 154 | MP0003011_delayed_dark_adaptation | 0.72668498 |
| 155 | MP0001188_hyperpigmentation | 0.72381113 |
| 156 | MP0003693_abnormal_embryo_hatching | 0.72059666 |
| 157 | MP0005330_cardiomyopathy | 0.68596342 |
| 158 | MP0001293_anophthalmia | 0.68382850 |
| 159 | MP0008775_abnormal_heart_ventricle | 0.66712386 |
| 160 | MP0005503_abnormal_tendon_morphology | 0.66335994 |
| 161 | MP0010386_abnormal_urinary_bladder | 0.65287740 |
| 162 | MP0001879_abnormal_lymphatic_vessel | 0.64855039 |
| 163 | MP0002234_abnormal_pharynx_morphology | 0.64342380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 6.00742531 |
| 2 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.01664527 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.32226583 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.32226583 |
| 5 | Neurofibrillary tangles (HP:0002185) | 3.98627930 |
| 6 | Peripheral hypomyelination (HP:0007182) | 3.81516067 |
| 7 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.80743477 |
| 8 | Increased serum pyruvate (HP:0003542) | 3.69138868 |
| 9 | Abnormality of glycolysis (HP:0004366) | 3.69138868 |
| 10 | Anomalous pulmonary venous return (HP:0010772) | 3.51365006 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 3.43347318 |
| 12 | Cerebral hypomyelination (HP:0006808) | 3.32497336 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.25751646 |
| 14 | Delayed gross motor development (HP:0002194) | 3.20323249 |
| 15 | Abnormality of the pulmonary veins (HP:0011718) | 3.19688817 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.19511715 |
| 17 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.97391726 |
| 18 | Abnormality of the corticospinal tract (HP:0002492) | 2.92715029 |
| 19 | Renal Fanconi syndrome (HP:0001994) | 2.88778351 |
| 20 | Sensory axonal neuropathy (HP:0003390) | 2.83761403 |
| 21 | Progressive macrocephaly (HP:0004481) | 2.79340034 |
| 22 | Leukodystrophy (HP:0002415) | 2.79092957 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.77798577 |
| 24 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.77798577 |
| 25 | Onion bulb formation (HP:0003383) | 2.72705796 |
| 26 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.72111752 |
| 27 | Stenosis of the external auditory canal (HP:0000402) | 2.71430072 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.71032963 |
| 29 | Acute encephalopathy (HP:0006846) | 2.70375358 |
| 30 | Congenital, generalized hypertrichosis (HP:0004540) | 2.66750242 |
| 31 | Abnormality of secondary sexual hair (HP:0009888) | 2.58702509 |
| 32 | Abnormality of the axillary hair (HP:0100134) | 2.58702509 |
| 33 | Increased hepatocellular lipid droplets (HP:0006565) | 2.57486158 |
| 34 | Methylmalonic aciduria (HP:0012120) | 2.56013867 |
| 35 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.53575198 |
| 36 | Hypoplastic pelvis (HP:0008839) | 2.52137860 |
| 37 | Hepatic necrosis (HP:0002605) | 2.50039719 |
| 38 | Increased CSF lactate (HP:0002490) | 2.49583441 |
| 39 | Myelomeningocele (HP:0002475) | 2.48602982 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 2.47938836 |
| 41 | Cerebral edema (HP:0002181) | 2.47080660 |
| 42 | Conical tooth (HP:0000698) | 2.43840570 |
| 43 | Retinal dysplasia (HP:0007973) | 2.40403263 |
| 44 | Aplasia involving bones of the extremities (HP:0009825) | 2.38089080 |
| 45 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.38089080 |
| 46 | Aplasia of the phalanges of the hand (HP:0009802) | 2.38089080 |
| 47 | Absent septum pellucidum (HP:0001331) | 2.37530731 |
| 48 | Follicular hyperkeratosis (HP:0007502) | 2.37367610 |
| 49 | Autoamputation (HP:0001218) | 2.34595428 |
| 50 | 3-Methylglutaconic aciduria (HP:0003535) | 2.33954983 |
| 51 | Adrenal hypoplasia (HP:0000835) | 2.32582815 |
| 52 | Erythroderma (HP:0001019) | 2.32449337 |
| 53 | Nemaline bodies (HP:0003798) | 2.29967985 |
| 54 | Lipid accumulation in hepatocytes (HP:0006561) | 2.22405195 |
| 55 | Abnormality of the septum pellucidum (HP:0007375) | 2.21851266 |
| 56 | Abnormal auditory evoked potentials (HP:0006958) | 2.19733183 |
| 57 | Cardiovascular calcification (HP:0011915) | 2.18952221 |
| 58 | Alacrima (HP:0000522) | 2.18452459 |
| 59 | Cupped ear (HP:0000378) | 2.17118411 |
| 60 | Meningioma (HP:0002858) | 2.17005235 |
| 61 | Hypomagnesemia (HP:0002917) | 2.16123141 |
| 62 | Cerebral hemorrhage (HP:0001342) | 2.15431181 |
| 63 | Lactic acidosis (HP:0003128) | 2.13951213 |
| 64 | Delusions (HP:0000746) | 2.13642744 |
| 65 | Increased serum lactate (HP:0002151) | 2.13321886 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.12098084 |
| 67 | Abnormality of alanine metabolism (HP:0010916) | 2.10416342 |
| 68 | Hyperalaninemia (HP:0003348) | 2.10416342 |
| 69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.10416342 |
| 70 | Optic disc pallor (HP:0000543) | 2.09867431 |
| 71 | Exercise-induced muscle cramps (HP:0003710) | 2.09507239 |
| 72 | CNS hypomyelination (HP:0003429) | 2.09135442 |
| 73 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.08246744 |
| 74 | Exertional dyspnea (HP:0002875) | 2.08236691 |
| 75 | Muscle fiber inclusion bodies (HP:0100299) | 2.07814776 |
| 76 | Short tibia (HP:0005736) | 2.07225875 |
| 77 | Premature rupture of membranes (HP:0001788) | 2.06071576 |
| 78 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.05847739 |
| 79 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.05362272 |
| 80 | Patchy hypopigmentation of hair (HP:0011365) | 2.05126730 |
| 81 | Abnormality of the anterior horn cell (HP:0006802) | 2.04181853 |
| 82 | Degeneration of anterior horn cells (HP:0002398) | 2.04181853 |
| 83 | Conjunctival hamartoma (HP:0100780) | 2.03577205 |
| 84 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.02284782 |
| 85 | Fused cervical vertebrae (HP:0002949) | 2.01303283 |
| 86 | Respiratory failure (HP:0002878) | 2.01242381 |
| 87 | Slow saccadic eye movements (HP:0000514) | 2.01207796 |
| 88 | Vascular calcification (HP:0004934) | 1.99242951 |
| 89 | Spastic paraparesis (HP:0002313) | 1.97148784 |
| 90 | Exercise intolerance (HP:0003546) | 1.96224645 |
| 91 | Type I transferrin isoform profile (HP:0003642) | 1.95765086 |
| 92 | Vaginal atresia (HP:0000148) | 1.95429085 |
| 93 | Mixed hearing impairment (HP:0000410) | 1.95275623 |
| 94 | Genital tract atresia (HP:0001827) | 1.95257121 |
| 95 | Irregular epiphyses (HP:0010582) | 1.94883337 |
| 96 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.94749984 |
| 97 | Abnormality of renal resorption (HP:0011038) | 1.94009181 |
| 98 | Septo-optic dysplasia (HP:0100842) | 1.93441480 |
| 99 | Lethargy (HP:0001254) | 1.92923248 |
| 100 | Split foot (HP:0001839) | 1.92357731 |
| 101 | Abnormality of methionine metabolism (HP:0010901) | 1.91013961 |
| 102 | Morphological abnormality of the inner ear (HP:0011390) | 1.90468131 |
| 103 | Ulnar claw (HP:0001178) | 1.90293292 |
| 104 | Supranuclear gaze palsy (HP:0000605) | 1.90137041 |
| 105 | Hypoplastic left heart (HP:0004383) | 1.90026390 |
| 106 | Axonal loss (HP:0003447) | 1.89858277 |
| 107 | Pancreatic fibrosis (HP:0100732) | 1.87986303 |
| 108 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87915709 |
| 109 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87915709 |
| 110 | Abnormal protein glycosylation (HP:0012346) | 1.87915709 |
| 111 | Abnormal glycosylation (HP:0012345) | 1.87915709 |
| 112 | Hepatosplenomegaly (HP:0001433) | 1.85595006 |
| 113 | Decreased lacrimation (HP:0000633) | 1.83682178 |
| 114 | Nasolacrimal duct obstruction (HP:0000579) | 1.82741187 |
| 115 | White forelock (HP:0002211) | 1.82611280 |
| 116 | Abnormality of placental membranes (HP:0011409) | 1.81580862 |
| 117 | Amniotic constriction ring (HP:0009775) | 1.81580862 |
| 118 | Sparse eyelashes (HP:0000653) | 1.81133852 |
| 119 | Methylmalonic acidemia (HP:0002912) | 1.80093612 |
| 120 | Hypothermia (HP:0002045) | 1.79755767 |
| 121 | Termporal pattern (HP:0011008) | 1.78578303 |
| 122 | Insidious onset (HP:0003587) | 1.78578303 |
| 123 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78526471 |
| 124 | Postnatal microcephaly (HP:0005484) | 1.78455143 |
| 125 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.78286572 |
| 126 | Hypokinesia (HP:0002375) | 1.78048280 |
| 127 | Abnormality of serum amino acid levels (HP:0003112) | 1.77970141 |
| 128 | Anhidrosis (HP:0000970) | 1.76078631 |
| 129 | Poor suck (HP:0002033) | 1.75533826 |
| 130 | Esophageal atresia (HP:0002032) | 1.75445072 |
| 131 | Thickened helices (HP:0000391) | 1.75044337 |
| 132 | Redundant skin (HP:0001582) | 1.74435427 |
| 133 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.74105378 |
| 134 | Ankle contracture (HP:0006466) | 1.72206252 |
| 135 | Hypoplasia of the uterus (HP:0000013) | 1.72140764 |
| 136 | Short hallux (HP:0010109) | 1.72127243 |
| 137 | X-linked dominant inheritance (HP:0001423) | 1.72034171 |
| 138 | Septate vagina (HP:0001153) | 1.71216680 |
| 139 | Concave nail (HP:0001598) | 1.70860171 |
| 140 | Fibular aplasia (HP:0002990) | 1.70765496 |
| 141 | Metaphyseal dysplasia (HP:0100255) | 1.70569176 |
| 142 | Oral leukoplakia (HP:0002745) | 1.70463203 |
| 143 | Seborrheic dermatitis (HP:0001051) | 1.69024213 |
| 144 | CNS demyelination (HP:0007305) | 1.68736697 |
| 145 | Increased intramyocellular lipid droplets (HP:0012240) | 1.68719445 |
| 146 | Spastic gait (HP:0002064) | 1.67106472 |
| 147 | Neuroendocrine neoplasm (HP:0100634) | 1.67086164 |
| 148 | Furrowed tongue (HP:0000221) | 1.66709329 |
| 149 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.66255558 |
| 150 | Brittle hair (HP:0002299) | 1.65714546 |
| 151 | Limb dystonia (HP:0002451) | 1.65553466 |
| 152 | Abnormality of incisor morphology (HP:0011063) | 1.65123329 |
| 153 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.65048739 |
| 154 | Partial duplication of thumb phalanx (HP:0009944) | 1.64577527 |
| 155 | Stomach cancer (HP:0012126) | 1.64284636 |
| 156 | Meningocele (HP:0002435) | 1.64268298 |
| 157 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.63627228 |
| 158 | Short 1st metacarpal (HP:0010034) | 1.63627228 |
| 159 | Pancreatic cysts (HP:0001737) | 1.63476147 |
| 160 | Hypoglycemic coma (HP:0001325) | 1.63102021 |
| 161 | Progressive inability to walk (HP:0002505) | 1.62847591 |
| 162 | Tongue fasciculations (HP:0001308) | 1.61743227 |
| 163 | Poor head control (HP:0002421) | 1.61528331 |
| 164 | Abnormality of glycolipid metabolism (HP:0010969) | 1.61379381 |
| 165 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.61379381 |
| 166 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.61379381 |
| 167 | Type 1 muscle fiber predominance (HP:0003803) | 1.59921992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.23877717 |
| 2 | PBK | 3.64042565 |
| 3 | MST4 | 3.50026719 |
| 4 | OXSR1 | 3.34090764 |
| 5 | BCR | 3.00755600 |
| 6 | LIMK1 | 2.85200295 |
| 7 | TESK2 | 2.74558380 |
| 8 | MAPKAPK5 | 2.61881308 |
| 9 | MAP3K12 | 2.35631718 |
| 10 | TSSK6 | 2.29750375 |
| 11 | EIF2AK1 | 2.29689533 |
| 12 | EPHB1 | 2.28249971 |
| 13 | WNK4 | 2.21624802 |
| 14 | ERBB3 | 2.15979731 |
| 15 | TRIM28 | 2.15581676 |
| 16 | STK38L | 2.02002615 |
| 17 | PKN1 | 1.92020879 |
| 18 | LATS2 | 1.84794900 |
| 19 | DYRK2 | 1.82316768 |
| 20 | MET | 1.79023355 |
| 21 | CASK | 1.72665732 |
| 22 | PLK3 | 1.69171211 |
| 23 | CSNK1G3 | 1.66789889 |
| 24 | WNK3 | 1.65433832 |
| 25 | WEE1 | 1.54807179 |
| 26 | NEK1 | 1.48893672 |
| 27 | PDK2 | 1.47809492 |
| 28 | BMPR1B | 1.45710027 |
| 29 | PNCK | 1.45426177 |
| 30 | TNIK | 1.44079071 |
| 31 | MYLK | 1.42127870 |
| 32 | CSNK1A1L | 1.38976059 |
| 33 | CSNK1G1 | 1.38778743 |
| 34 | NEK6 | 1.36528347 |
| 35 | FRK | 1.36210773 |
| 36 | CDK19 | 1.34927036 |
| 37 | SRPK1 | 1.33467621 |
| 38 | ARAF | 1.29496259 |
| 39 | NME1 | 1.28803729 |
| 40 | STK16 | 1.27917635 |
| 41 | FGR | 1.27129471 |
| 42 | CSNK1G2 | 1.25496772 |
| 43 | BRSK2 | 1.25156351 |
| 44 | CAMK2B | 1.23896711 |
| 45 | ACVR1B | 1.23857630 |
| 46 | BUB1 | 1.22393269 |
| 47 | MUSK | 1.13303549 |
| 48 | WNK1 | 1.12295870 |
| 49 | MKNK1 | 1.09110572 |
| 50 | IRAK3 | 1.08272092 |
| 51 | PINK1 | 1.07452561 |
| 52 | NEK9 | 1.06740862 |
| 53 | ROCK2 | 1.06420975 |
| 54 | FGFR2 | 1.05257367 |
| 55 | UHMK1 | 1.03692373 |
| 56 | GRK7 | 1.00511894 |
| 57 | PIM2 | 0.97978559 |
| 58 | PLK4 | 0.97945552 |
| 59 | BMPR2 | 0.96421128 |
| 60 | SIK3 | 0.94751699 |
| 61 | CDC7 | 0.94360371 |
| 62 | ZAK | 0.93905190 |
| 63 | CAMK2D | 0.93874776 |
| 64 | STK3 | 0.92543074 |
| 65 | MAP4K2 | 0.90908701 |
| 66 | NTRK1 | 0.90848962 |
| 67 | TLK1 | 0.89780884 |
| 68 | GRK1 | 0.87551871 |
| 69 | VRK2 | 0.82357777 |
| 70 | CAMK2G | 0.81217308 |
| 71 | PLK1 | 0.80993333 |
| 72 | GRK5 | 0.80974817 |
| 73 | PRKCE | 0.80800943 |
| 74 | VRK1 | 0.79633711 |
| 75 | RPS6KA5 | 0.79569410 |
| 76 | TRPM7 | 0.79229955 |
| 77 | PAK4 | 0.77663640 |
| 78 | CAMK2A | 0.74120600 |
| 79 | DYRK1A | 0.74108222 |
| 80 | TGFBR1 | 0.73639906 |
| 81 | SGK494 | 0.72849521 |
| 82 | SGK223 | 0.72849521 |
| 83 | MAP3K9 | 0.71693699 |
| 84 | MARK1 | 0.71255126 |
| 85 | PAK2 | 0.69932032 |
| 86 | TTK | 0.69577965 |
| 87 | MAP2K2 | 0.69369725 |
| 88 | ERBB4 | 0.68584650 |
| 89 | PRKCG | 0.66198842 |
| 90 | PTK2 | 0.66074392 |
| 91 | NME2 | 0.64778652 |
| 92 | CLK1 | 0.61841925 |
| 93 | PRKCQ | 0.61809284 |
| 94 | PLK2 | 0.60655002 |
| 95 | MAPK15 | 0.59546200 |
| 96 | EIF2AK3 | 0.58000518 |
| 97 | MKNK2 | 0.56976206 |
| 98 | PAK3 | 0.56558151 |
| 99 | EIF2AK2 | 0.56508126 |
| 100 | ABL2 | 0.56401740 |
| 101 | CDK14 | 0.55944593 |
| 102 | BLK | 0.55368140 |
| 103 | FER | 0.55126518 |
| 104 | MAPK13 | 0.55023258 |
| 105 | MST1R | 0.54766292 |
| 106 | TIE1 | 0.53859493 |
| 107 | INSRR | 0.53325267 |
| 108 | CDK8 | 0.52712460 |
| 109 | TESK1 | 0.52287243 |
| 110 | PAK6 | 0.51992740 |
| 111 | NTRK2 | 0.50733833 |
| 112 | BRAF | 0.48680599 |
| 113 | DDR2 | 0.47984725 |
| 114 | AKT3 | 0.47511645 |
| 115 | EPHA2 | 0.47375985 |
| 116 | PRKD1 | 0.46708259 |
| 117 | NUAK1 | 0.45120819 |
| 118 | CDK3 | 0.44929761 |
| 119 | PRKG1 | 0.44838190 |
| 120 | NLK | 0.44771544 |
| 121 | MAP3K4 | 0.44413813 |
| 122 | YES1 | 0.44372561 |
| 123 | PRKCI | 0.44314169 |
| 124 | DYRK3 | 0.43658036 |
| 125 | CDK5 | 0.43106034 |
| 126 | EPHB2 | 0.43086020 |
| 127 | ROCK1 | 0.40408457 |
| 128 | KSR1 | 0.39828678 |
| 129 | CSNK1A1 | 0.39161404 |
| 130 | MOS | 0.39042490 |
| 131 | PTK2B | 0.38720593 |
| 132 | ADRBK1 | 0.38459235 |
| 133 | PIK3CA | 0.37544767 |
| 134 | ADRBK2 | 0.36352937 |
| 135 | ITK | 0.36001872 |
| 136 | STK24 | 0.35865614 |
| 137 | IRAK1 | 0.35477240 |
| 138 | CDK15 | 0.35440912 |
| 139 | PRKACA | 0.35438745 |
| 140 | CDK18 | 0.34395186 |
| 141 | OBSCN | 0.34324816 |
| 142 | PAK1 | 0.32857187 |
| 143 | PIK3CG | 0.31871969 |
| 144 | MAP2K7 | 0.31650604 |
| 145 | GSK3A | 0.31593145 |
| 146 | CDK11A | 0.31499030 |
| 147 | PHKG1 | 0.31143835 |
| 148 | PHKG2 | 0.31143835 |
| 149 | STK4 | 0.29830745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.43121564 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.09925055 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.09586742 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.79352220 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.92003164 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.87087723 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.81103540 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.65080655 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.64289076 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.46483579 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.35204162 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.32823437 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 2.31404592 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.24768124 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.06047191 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.03112263 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.98050298 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.91266338 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83718786 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79971943 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69194766 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.66529546 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54324757 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.48334433 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36636945 |
| 26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.36431604 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28735006 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21203515 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18572802 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17273519 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.14206481 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 1.14016499 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.13344092 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12727875 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11360081 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.11134516 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10676670 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09058776 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.07427536 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.05582199 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05193707 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.04810096 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.04570499 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.03704399 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02605205 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02376265 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01111706 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00966055 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00876267 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00500576 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98887816 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94532025 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93309737 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90147383 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90050635 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89240047 |
| 57 | Spliceosome_Homo sapiens_hsa03040 | 0.84091205 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.83879229 |
| 59 | * Basal transcription factors_Homo sapiens_hsa03022 | 0.83270738 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82815528 |
| 61 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82271778 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.80504505 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75325895 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74786401 |
| 65 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.74493540 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73870244 |
| 67 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72695740 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71659929 |
| 69 | Mismatch repair_Homo sapiens_hsa03430 | 0.70857573 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70047418 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67871374 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66359657 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65574239 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65424970 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64906822 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64872527 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62428729 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61929845 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.61832988 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61065573 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60092854 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60044551 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59907165 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59237155 |
| 85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55613533 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55437314 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55393556 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55211627 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54546693 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54546178 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53504812 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53418658 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51627415 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51076366 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50071409 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49527244 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48551537 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47700776 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47588527 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.47059063 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46553219 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.45311166 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44547266 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43732012 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43403580 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43195265 |
| 107 | Peroxisome_Homo sapiens_hsa04146 | 0.42850171 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.41808816 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41682973 |
| 110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40684409 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39245719 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.39013108 |
| 113 | Asthma_Homo sapiens_hsa05310 | 0.37227607 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36049759 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.35187894 |
| 116 | Shigellosis_Homo sapiens_hsa05131 | 0.35179207 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.34646983 |
| 118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33997914 |
| 119 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32452615 |
| 120 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31389495 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30602541 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.29837921 |
| 123 | Cocaine addiction_Homo sapiens_hsa05030 | 0.28202991 |
| 124 | Cell cycle_Homo sapiens_hsa04110 | 0.26522662 |
| 125 | DNA replication_Homo sapiens_hsa03030 | 0.23475927 |
| 126 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.23323957 |
| 127 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22830250 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22356839 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20320025 |
| 130 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.20216309 |
| 131 | Lysosome_Homo sapiens_hsa04142 | 0.19130135 |
| 132 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.18306069 |
| 133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.17867236 |
| 134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.16046704 |
| 135 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.16020642 |
| 136 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.15561915 |
| 137 | Morphine addiction_Homo sapiens_hsa05032 | 0.14814077 |
| 138 | Nicotine addiction_Homo sapiens_hsa05033 | 0.14279527 |
| 139 | Taste transduction_Homo sapiens_hsa04742 | 0.13326269 |
| 140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.12754313 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.12544813 |
| 142 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.11077569 |
| 143 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.08892659 |
| 144 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.08579828 |

